What Strand AI does
Strand AI develops multimodal foundation models that predict uncollected patient biology. Given whatever biological data a patient already has, such as a routine blood draw or a tumor slide, its models predict the data that is missing, including gene expression, proteomics, and spatial transcriptomics, building a more complete biological picture.
Key capabilities
Strand AI's foundation model integrates multiple biological modalities including genomics, RNA, proteins, imaging, and clinical outcomes. By imputing missing data, the company aims to help pharmaceutical teams select better patients for clinical trials and shorten drug development timelines, addressing the high failure rate and cost of trials. The company reports training a multimodal model that integrates spatial biology modalities.
Who it's for
Strand AI serves pharmaceutical and life sciences companies and drug discovery teams that need richer multimodal patient data to improve trial design and patient selection. It is part of Y Combinator's batch.